Most Read

Top stories

On Monday, September 24th, the Trump Administration canceled a human fetal tissue research contract that had been brokered by the Food and Drug Administration (FDA) with a company called Advanced Bioscience Resources on the grounds that “serious regulatory, moral, and ethical considerations” needed to be investigated. The Department of Health and Human Services (HHS) further stated that it would determine if “adequate alternatives exist to the use of human fetal tissue in HHS funded research and will ensure that efforts to develop such alternatives are funded and accelerated.”

The debate over how to ethically utilize embryonic stem cells for the discovery and development of new therapeutics for difficult-to-treat medical conditions dogged prior presidents and has now morphed into the fetal tissue controversy that the current administration has engaged.

Keep reading...Show less